pembrolizumab,axicabtagene ciloleucel
merck,gilead sciences,daiichi sankyo
['pembro']
 favorable risk patients in pembro/axi could be a confounder?
Onc Fellow @uoaofficial Alexandra Hospital_ Proud Olympiacos Fan_Gifted underachiever